Eris Biotech
Site unreachableOur drugs engage the immune system to fight tumors
What it does
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
Next to it in Healthcare and bio · Immuno-oncology small molecule therapeutics
- Altay TherapeuticsY Combinator W20
Altay develops disease-modifying therapies targeting transcription…
- Serna BioY Combinator W21
Genetic Medicine with Small Molecules
- FREZENT Biological SolutionsSOSV SOSV IndieBio NY 07
Changing the prognosis for patients with advanced stage cancer
- SynsoryBioY Combinator W24
"If-then" conditional logic for protein drugs
- Palate TherapeuticsSOSV SOSV IndieBio NY 06
Unlock the Taste of Health
- Scioto BiosciencesPlug and Play PnP 2025
Scioto is a preclinical stage company developing innovative therapies devoted to having a transformative impact.
- AlixiaY Combinator W22
Targeting the Tumor Ecosystem to address cancer drug resistance.
- Origami Therapeutics, Inc.Y Combinator W22
Oral drugs to halt neurodegeneration